Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy

NCT06662994 is registered in ClinicalTrials.gov with Retina Consultants of Orange County as lead sponsor.

NCT NCT06662994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06662994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy
Lead sponsor
Retina Consultants of Orange County
Phase
Phase 4
Overall status
Recruiting
Start date
July 7, 2025
Completion date
August 15, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema (dme)